Ocean Biomedical Inc
NASDAQ:OCEA
Cash Flow Statement
Cash Flow Statement
Ocean Biomedical Inc
| Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(79)
|
(85)
|
(102)
|
(114)
|
(34)
|
(38)
|
(27)
|
(9)
|
|
| Stock-Based Compensation |
18
|
13
|
4
|
1
|
(9)
|
(9)
|
1
|
1
|
|
| Other Non-Cash Items |
72
|
76
|
90
|
104
|
27
|
33
|
24
|
4
|
|
| Change in Working Capital |
5
|
1
|
3
|
1
|
(0)
|
2
|
0
|
1
|
|
| Cash from Operating Activities |
(3)
N/A
|
(8)
-142%
|
(9)
-14%
|
(9)
-4%
|
(7)
+23%
|
(3)
+62%
|
(3)
+9%
|
(4)
-65%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
14
|
14
|
14
|
14
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
1
|
6
|
6
|
7
|
6
|
1
|
2
|
3
|
|
| Other |
(12)
|
(11)
|
(11)
|
(11)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
3
N/A
|
10
+194%
|
10
N/A
|
10
+7%
|
7
-28%
|
1
-89%
|
2
+107%
|
3
+96%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
0
N/A
|
2
+17 500%
|
1
-64%
|
1
+55%
|
0
-78%
|
(2)
N/A
|
(1)
+59%
|
(1)
+1%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(3)
N/A
|
(8)
-142%
|
(9)
-14%
|
(9)
-4%
|
(7)
+23%
|
(3)
+62%
|
(3)
+9%
|
(4)
-65%
|
|